hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies (IRO’s). As a leading global site network, hyperCORE is comprised of more than 100 sites across 5 countries on 2 continents. Its unique ownership model combines the strengths of 10 leading independent research site alliance partner companies under one umbrella. The hyperCORE network model is focused on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs. Its member companies have over 100 years of combined experience and completed more than 7,000 studies helping to evaluate thousands of new drugs and treatments in more than 140,000 patients.
Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.
hyperCORE’s partner members are:
AGA Clinical Trials of Hialeah, Florida
Alcanza Clinical Research of Methuen, Massachusetts
Apex Trials (NutraSource) of Guelph, Ontario, Canada
Applied Research Center of Arkansas, Little Rock, Arkansas
CaRe Clinic of Calgary, Alberta, Canada
FOMAT Medical Research of Oxnard, California
TrueBlue Clinical Research of Tampa, Florida
QCR Network of Omaha, Nebraska
-
Industry
-
Research Services
-
Company size
-
201-500 employees
-
Headquarters
-
Wilmington, Delaware
-
Type
-
Partnership
-
Founded
-
2019
-
Specialties
-
clinical research, research studies, clinical trials, clinical studies, diversity, equity, inclusion, trial execution, data integrity, and patient recruitment
